3/8/23 16:05 | 3/6/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.m | -630 | 9.55 | 0 | -66 | -96 | 3 | D | | | | | | | | | | | | | | |
3/7/23 16:14 | 3/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.dm | 0 | 0.00 | 0 | 66 | 999% | 69 | D | | | | | | | | | | | | | | |
3/2/23 07:38 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 63 | | 3 | D | | | | | | | | | | | | | | |
3/2/23 07:38 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -627 | 9.89 | 0 | -63 | -96 | 3 | D | | | | | | | | | | | | | | |
7/29/22 07:02 | 7/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S | -526 | 9.04 | 0 | -58 | -95 | 3 | D | | | | | | | | | | | | | | |
3/8/22 16:13 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.dm | 0 | 0.00 | 0 | 72 | | 61 | D | | | | | | | | | | | | | | |
3/8/22 16:13 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.dm | -241 | 7.45 | 0 | -32 | -35 | 61 | D | | | | | | | | | | | | | | |
3/2/22 07:54 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 18 | 625 | 21 | D | | | | | | | | | | | | | | |
3/2/22 07:54 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -53 | 8.14 | 0 | -6 | -23 | 21 | D | | | | | | | | | | | | | | |
2/10/22 16:13 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 13 | | 9 | D | | | | | | | | | | | | | | |
2/10/22 16:13 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -55 | 9.06 | 0 | -6 | -39 | 9 | D | | | | | | | | | | | | | | |
5/13/21 07:48 | 5/11/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 38 | | 3 | D | | | | | | | | | | | | | | |
5/13/21 07:48 | 5/11/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -387 | 10.22 | 0 | -38 | -93 | 3 | D | | | | | | | | | | | | | | |
3/8/21 16:12 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 14 | | 3 | D | | | | | | | | | | | | | | |
3/8/21 16:12 | 3/4/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -147 | 10.57 | 0 | -14 | -82 | 3 | D | | | | | | | | | | | | | | |
3/2/21 16:10 | 2/28/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 18 | | 3 | D | | | | | | | | | | | | | | |
3/2/21 16:10 | 3/1/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -200 | 10.83 | 0 | -18 | -86 | 3 | D | | | | | | | | | | | | | | |
2/17/21 16:09 | 2/14/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
2/17/21 16:09 | 2/16/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -44 | 11.12 | 0 | -4 | -57 | 3 | D | | | | | | | | | | | | | | |
2/11/21 16:12 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 13 | | 3 | D | | | | | | | | | | | | | | |
2/11/21 16:12 | 2/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -829 | 12.69 | 0 | -65 | -96 | 3 | D | | | | | | | | | | | | | | |
3/19/20 07:38 | 3/17/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 2 | 383 | 3 | D | | | | | | | | | | | | | | |
3/19/20 07:38 | 3/17/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -17 | 7.16 | 0 | -2 | -44 | 3 | D | | | | | | | | | | | | | | |
2/18/20 07:26 | 2/14/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 17 | | 3 | D | | | | | | | | | | | | | | |
2/18/20 07:26 | 2/14/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -207 | 12.14 | 0 | -17 | -85 | 3 | D | | | | | | | | | | | | | | |
2/11/20 07:06 | 2/9/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 13 | | 3 | D | | | | | | | | | | | | | | |
2/11/20 07:06 | 2/10/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -153 | 12.24 | 0 | -13 | -81 | 3 | D | | | | | | | | | | | | | | |
3/19/19 08:11 | 3/17/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 2 | 383 | 3 | D | | | | | | | | | | | | | | |
3/19/19 08:11 | 3/18/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -39 | 16.43 | 0 | -2 | -44 | 3 | D | | | | | | | | | | | | | | |
3/14/19 07:44 | 3/12/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 2 | 461 | 3 | D | | | | | | | | | | | | | | |
3/14/19 07:44 | 3/12/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -39 | 15.82 | 0 | -2 | -45 | 3 | D | | | | | | | | | | | | | | |
2/19/19 07:26 | 2/14/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
2/19/19 07:26 | 2/14/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -70 | 17.74 | 0 | -4 | -57 | 3 | D | | | | | | | | | | | | | | |
3/20/18 16:16 | 3/17/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 2 | 383 | 3 | D | | | | | | | | | | | | | | |
3/20/18 16:16 | 3/19/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -43 | 18.38 | 0 | -2 | -44 | 3 | D | | | | | | | | | | | | | | |
3/14/18 16:35 | 3/12/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | M.d | 0 | 0.00 | 0 | 2 | 458 | 3 | D | | | | | | | | | | | | | | |
3/14/18 16:35 | 3/12/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Stark David Matthew | L3 | O | EVP GC | S.d | -47 | 19.20 | 0 | -2 | -45 | 3 | D | | | | | | | | | | | | | | |